Ueda Hiroshi (Tokyo Tech), Nakano Hideo (Nagoya Univ.) |
Most recent update: 2022-01-31 16:50:01
The keywords that frequently used in this topics code. | Keywords | Number | |
---|---|---|---|
COVID-19 | 3 | ||
Modified Nucleosides | 2 | ||
Peptide ligation | 1 |
ACKN No. | Title/Author(s) | Keywords | Style |
---|---|---|---|
84 | [Requested talk] Progress in the diagnosis of COVID-19 - Automated PCR and novel technology | COVID-19 PCR Diagnosis | O |
194 | [Invited lecture] Exploring new biomarkers for COVID-19 using comprehensive analysis of modified nucleosides | Modified Nucleosides COVID-19 | O |
195 | [Requested talk] Development of LC/MS/MS analysis method for modified nucleosides associated with aggravation of COVID-19 patients | Modified Nucleosides COVID-19 | O |
263 | [Invited lecture] Rapid In Vitro Selection of Antibody-like Proteins Against SARS-CoV-2 | Antibody-like protein TRAP display Spike protein | O |
733 | Quenchbody-based 1-minute detection assay for SARS-CoV-2 and variants of concern | SARS-CoV-2 Quenchbody Variants of concern | O |
779 | Peptide ligation for generating reconstructed antibodies from E. coli expression | Peptide ligation Microbial transglutaminase Antibody | O |